TNF-α通过CD8+ T细胞介导内皮损伤驱动重症急性胰腺炎胰腺微循环障碍
该研究基于8例重症急性胰腺炎(SAP)患者胰腺组织构建首个单细胞转录组图谱,结合153例临床队列及小鼠和猪模型验证,发现胰腺微循环衰竭是SAP核心病理事件。TNF-α上调内皮细胞ULBPs,激活浸润CD8+ T细胞NKG2D受体,形成正反馈环路放大微血管损伤;抑制TNF-α或CD8+ T细胞可保护微血管完整性、减少组织损伤并改善生存。
要点
- SAP胰腺微循环衰竭由CD8+ T细胞介导的内皮损伤驱动。
- TNF-α/ULBP/NKG2D轴与临床疾病严重程度及微循环障碍相关。
- 抑制TNF-α或CD8+ T细胞在临床前模型中保护微血管并改善生存。
核心结论
- TNF-α/ULBP/NKG2D轴驱动的免疫-内皮环路是SAP微循环障碍的关键机制,靶向TNF-α具有治疗潜力。
研究设计与样本
- 研究利用8例危重SAP患者罕见胰腺组织构建首个人类SAP单细胞转录组图谱。
- findings整合153例大型患者队列临床数据,并通过小鼠和猪模型的体外与体内研究验证。
主要发现
- 胰腺微循环衰竭是SAP中心病理事件,由CD8+ T细胞介导的内皮损伤驱动。
- TNF-α上调内皮细胞ULBPs,激活浸润CD8+ T细胞NKG2D,形成正反馈环路放大微血管损伤。
- TNF-α/ULBP/NKG2D轴与患者临床疾病严重程度和微循环功能障碍相关。
- 临床前模型中抑制TNF-α或CD8+ T细胞可保护微血管完整性、减少组织损伤并改善生存。
临床怎么用
- TNF-α/ULBP/NKG2D轴可作为SAP疾病严重程度和微循环障碍的机制相关标志。
- 靶向TNF-α或CD8+ T细胞可能成为SAP保护微循环、减轻组织损伤的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe acute pancreatitis (SAP) is a life-threatening inflammatory disorder characterised by progressive multiorgan dysfunction. Direct investigation of human pancreatic tissue in SAP has been extremely limited, and effective targeted therapies are currently lacking. OBJECTIVE: We sought to define the cellular and molecular mechanisms of SAP progression to identify actionable therapeutic targets. DESIGN: Using rare pancreatic tissues from critically ill patients with SAP (n = 8), we constructed the first single-cell transcriptomic atlas of human SAP. Cellular compositional changes and intercellular communication were analysed to elucidate disease mechanisms. Findings were integrated with clinical data from a large patient cohort (n = 153) and validated through in vitro and in vivo studies in murine and porcine models. RESULTS: We identified pancreatic microcirculatory failure as a central pathological event in SAP, driven by CD8+ T cell-mediated endothelial injury. Mechanistically, tumour necrosis factor-alpha (TNF-α) upregulates UL16-binding proteins (ULBPs) on endothelial cells, activating the cytotoxic receptor NKG2D on infiltrating CD8+ T cells and creating a feed-forward loop that amplifies microvascular damage. The TNF-α/ULBP/NKG2D axis correlated with clinical disease severity and microcirculatory dysfunction in patients. In preclinical models, inhibition of TNF-α or CD8+ T cells preserved microvascular integrity, reduced tissue damage and improved survival. CONCLUSION: This study provides the comprehensive cellular map of human SAP and uncovers a pathogenic immune-endothelial circuit-orchestrated by the TNF-α/ULBP/NKG2D axis-that drives microcirculatory dysfunction. These findings establish a mechanistic rationale for targeting TNF-α as a potential therapeutic strategy in SAP.
引用
- Shi L, Li W, Chen D, et al. TNF-α drives pancreatic microcirculatory dysfunction via CD8+ T cell-mediated endothelial injury in severe acute pancreatitis. Gut. 2026. PMID: 42236225. doi:10.1136/gutjnl-2025-337183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。